to lowering an individual’s risk of Alzheimer’s disease. This analysis was conducted by researchers at Case Western Reserve ...
A group of international experts is challenging revised diagnostic criteria for Alzheimer’s disease (AD) as laid out by the ...
Alzheimer’s currently affects over 55 million people worldwide, with cases expected to triple by 2050. Advances in diagnostic methods that are faster, less invasive, and more affordable could enable ...
After some time, early symptomatic Alzheimer's disease begins with a small amount of memory loss and confusion that can be ...
"We showed people with Alzheimer's disease have more gut inflammation," University of Wisconsin psychologist Barbara Bendlin ...
Each episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...
Semaglutide, the weight management drug sold as Ozempic and Wegovy, may reduce the risk of Alzheimer's disease by 40% to 70% ...
Find out what AI has already brought to Alzheimer's disease research and most importantly, what it can accomplish in the ...
Diagnosis of Alzheimer's Disease (AD) is currently largely based on the presence of biomarkers. This may lead to a problematic over-diagnosis if this is incorrectly interpreted.
New treatments for Alzheimer disease don’t reverse cognitive symptoms, but they do significantly slow progression. Evidence suggests that earlier treatment is most effective.
The Alzheimer's disease drug Kisunla will face major reimbursement challenges in the U.K. after the cost-effectiveness ...
The National Institutes of Health reports that incidences of Alzheimer's disease and other dementia increased by roughly 148 ...